Cancer Talk Blog

Three Roswell Park Experts Acknowledged as Influential Researchers

Roswell Park Comprehensive Cancer Center’s Igor Puzanov, MD, MSCI, FACP, Andrew Hyland, PhD, and Maciej Goniewicz, PhD, PharmD, have all recently been recognized as global scientific pioneers on Clarivate Plc’s Highly Cited Researchers list for 2020.

Wednesday, December 9, 2020 - 07:00 am

The Monarch system uses a handheld console (seen here), plus computer assisted navigation for robotic bronchoscopy

Article

Donations bring cutting-edge robotic bronchoscopy to Roswell Park

You can thank a community swimming pool for helping Patricia discover her lung cancer before it advanced.

Tuesday, December 8, 2020 - 09:35 am

Cancer Research & News

Prevention & Screening

Article

What cancer patients (and others) need to know about the COVID-19 vaccine

Revised 12/17/20

Amid a surge in COVID-19 infections, vaccination is beginning around the nation of the first FDA-authorized COVID-19 vaccine.

Monday, December 7, 2020 - 03:00 pm

Life & Wellness

Prevention & Screening

News

Novel Therapy is Safe for Non-Hodgkin Lymphoma Patients, Roswell Park-Led Study Finds

Roswell Park’s Francisco J. Hernandez-Ilizaliturri, MD, has been investigating a novel therapy for patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Dr. Hernandez-Ilizaliturri is presenting the team’s findings at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition.

Monday, December 7, 2020 - 07:00 am

News

Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance Mechanisms

A group of researchers led by Roswell Park's Maximillian Merz, MD, conducted the first prospective clinical trial investigating spatial heterogeneity in patients with either relapsed/refractory or newly diagnosed multiple myeloma and is presenting the findings at ASH 2020.

Monday, December 7, 2020 - 07:00 am

News

Roswell Park Leukemia Chief Shares Promising Findings on New Treatment Options at ASH 2020

Eunice Wang, MD, is leading multiple research efforts focused on different treatment approaches for acute myeloid leukemia (AML) patients. During the ASH Annual Meeting and Exposition, she is presenting data on two ongoing studies incorporating new treatment options.

Saturday, December 5, 2020 - 07:00 am

Dr. Philip McCarthy, MD, Director, Transplant and Cellular Therapy Center

News

Conference Watch: Experts from Roswell Park Sharing Insights at ASH and Bridge Meetings

Research and insights from the Roswell Park team will help to fuel three important research meetings in the week ahead as researchers in oncology, hematology and immunotherapy come together virtually for the Immunotherapy Bridge 2020 meeting, Melanoma Bridge 2020 meeting and 62nd American Society of Hematology (ASH) Annual Meeting and Exposition.

Wednesday, December 2, 2020 - 07:00 am

Article

New feature! One click can open all the benefits of the MyRoswell patient portal

Now there’s a faster, easier way to log into the MyRoswell patient portal — the online gateway to your Roswell Park medical records and other information.

Tuesday, December 1, 2020 - 02:31 pm

Cancer Support

Kara Rowe shares a moment with her daughter after ringing the Victory Bell.

Article

Three cancers by age 36: Kara’s story

“I owe my life to Roswell, and I give my doctors all the credit. For some reason, cancer likes my body, but I have to get through this. I don’t have any other choice."

Tuesday, December 1, 2020 - 09:28 am

Patient Stories